Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Piracetam for Treatment of Cocaine Addiction, Phase II - 4

This study has been withdrawn prior to enrollment.
Information provided by:
University of Pennsylvania Identifier:
First received: September 20, 1999
Last updated: July 25, 2013
Last verified: July 2013

The purpose of this study is to follow patients in Phase I of an inpatient study in an eight week open label assessment of piracetam in an outpatient treatment program.

Condition Intervention Phase
Cocaine-Related Disorders
Drug: Piracetam
Phase 1

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Piracetam for Treatment of Cocaine Addiction, Phase II

Further study details as provided by University of Pennsylvania:

Primary Outcome Measures:
  • Drug use
  • Adverse effects
  • Clinical status

Enrollment: 0

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Please contact site for information.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00000199

United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104 6178
Sponsors and Collaborators
University of Pennsylvania
Principal Investigator: Kyle Kampman, M.D. University of Pennsylvania
  More Information

No publications provided Identifier: NCT00000199     History of Changes
Other Study ID Numbers: NIDA-00238-4, K20DA000238, K02-00238-4
Study First Received: September 20, 1999
Last Updated: July 25, 2013
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cocaine-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Substance-Related Disorders processed this record on November 23, 2014